Article

Toll-Like Receptor 2 Promotes Breast Cancer Progression and Resistance to Chemotherapy

2021-11-01

Abstract excerpt

<title>Abstract</title> <p><bold>Background.</bold> Breast cancer (BC) is the leading cause of cancer death in women, due to the development of resistance to current therapies, including chemotherapy. Since breast cancer stem cells (CSCs) are the main drivers of therapy resistance and disease progression, chemoresistance might be prevented targeting the molecules that promote their self-renewal. We previously dem...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ffde03b1-f1a7-531f-915a-89f557c93f37
DOI: 10.21203/rs.3.rs-1015076/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Toll-Like Receptor 2 Promotes Breast Cancer Progression and Resistance to ChemotherapyDOI 10.21203/rs.3.rs-1015076/v1Read

β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer.Semantic proximity Read

Toll Like Receptor 4 and IFNγ Signalling axis as a therapeutic target in Triple negative Breast CancerSemantic proximity Read

Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.Semantic proximity Read

Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathwaySemantic proximity Read

Macrophages expressing chimeric cytokine receptors have an inflammatory phenotype and anti-tumoral activity upon IL-10 or TGFβ stimulationSemantic proximity Read

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancerSemantic proximity Read

Characteristics of the clinicopathology and immune microenvironment of the basal-like phenotype in HR+/HER2-breast cancerSemantic proximity Read

MCL-1 plays an oncogenic role in breast cancer by modulating chemoresistance and stemness properties by activating Wnt/β-cateninSemantic proximity Read

ONECUT2 governs the POU6F2-beta-catenin axis to modulate cancer stemness and drives the CCL28-dependent pathway for macrophage polarization in breast cancerSemantic proximity Read

The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape ProgramsSemantic proximity Read

TREM2 blockade reprograms HER2 CAR macrophages toward inflammatory phagocytes in breast cancer modelsSemantic proximity Read

Enhancing HLA-DR in Cytotoxic T Lymphocytes is crucial for the development of efficient adoptive T cell Therapies for Breast CancerSemantic proximity Read